{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:56:22Z","timestamp":1778162182571,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,20]]},"DOI":"10.7759\/cureus.71931","type":"journal-article","created":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T15:07:02Z","timestamp":1729436822000},"source":"Crossref","is-referenced-by-count":1,"title":["Intraoperative Diagnosis of Sodium-Glucose Transporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis"],"prefix":"10.7759","author":[{"given":"Bibek","family":"Devkota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Schaedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brant  M","family":"Wagener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishank Patel","family":"Nooli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000674","article-title":"Sodium-glucose cotransporter-2 inhibitors: an overview and perioperative implications","volume":"32","author":"Bardia A","year":"2019","unstructured":"Bardia A, Wai M, Fontes ML. Sodium-glucose cotransporter-2 inhibitors: an overview and perioperative implications. Curr Opin Anaesthesiol. 2019, 32:80-5. 10.1097\/ACO.0000000000000674","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2022.06.008","article-title":"Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors after cardiac surgery: a review of current literature","volume":"36","author":"Branco A","year":"2022","unstructured":"Branco A, Fatima R, Liblik K, Jackson R, Payne D, El-Diasty M. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors after cardiac surgery: a review of current literature. J Cardiothorac Vasc Anesth. 2022, 36:3877-86. 10.1053\/j.jvca.2022.06.008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-03051-3","article-title":"Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review","volume":"77","author":"Bamgboye AO","year":"2021","unstructured":"Bamgboye AO, Oni IO, Collier A. Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review. Eur J Clin Pharmacol. 2021, 77:651-7. 10.1007\/s00228-020-03051-3","journal-title":"Eur J Clin Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2022.06.007","article-title":"Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis: lessons from a case series of 4 patients undergoing coronary artery bypass grafting surgery","volume":"46","author":"Chaudhry A","year":"2022","unstructured":"Chaudhry A, Roels C, Lee J. Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis: lessons from a case series of 4 patients undergoing coronary artery bypass grafting surgery. Can J Diabetes. 2022, 46:843-50. 10.1016\/j.jcjd.2022.06.007","journal-title":"Can J Diabetes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.769041","article-title":"Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient who underwent surgery for pancreatic carcinoma: a case report","volume":"9","author":"Luo X","year":"2022","unstructured":"Luo X, Ji R, Lu W, Zhu H, Li L, Hu J. Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient who underwent surgery for pancreatic carcinoma: a case report. Front Surg. 2022, 9:769041. 10.3389\/fsurg.2022.769041","journal-title":"Front Surg"},{"key":"ref6","article-title":"Euglycemic diabetic ketoacidosis","author":"Plewa MC","year":"2023","unstructured":"Plewa MC, Bryant M, King-Thiele R. Euglycemic diabetic ketoacidosis. StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2019.03.014","article-title":"Euglycemic diabetic ketoacidosis","volume":"63","author":"Barski L","year":"2019","unstructured":"Barski L, Eshkoli T, Brandstaetter E, Jotkowitz A. Euglycemic diabetic ketoacidosis. Eur J Intern Med. 2019, 63:9-14. 10.1016\/j.ejim.2019.03.014","journal-title":"Eur J Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000311","article-title":"An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus","volume":"24","author":"Hsia DS","year":"2017","unstructured":"Hsia DS, Grove O, Cefalu WT. An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus. Curr Opin Endocrinol Diabetes Obes. 2017, 24:73-9. 10.1097\/MED.0000000000000311","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref9","article-title":"[Euglycemic diabetic ketoacidosis caused by a sodium-glucose co-transporter (SGLT) 2 inhibitor after coronary artery bypass grafting]","volume":"72","author":"Kameda Y","year":"2019","unstructured":"Kameda Y, Kato M, Inoue B, et al.. [Euglycemic diabetic ketoacidosis caused by a sodium-glucose co-transporter (SGLT) 2 inhibitor after coronary artery bypass grafting]. Kyobu Geka. 2019, 72:354-7.","journal-title":"Kyobu Geka"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.03.028","article-title":"Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review","volume":"123","author":"Thiruvenkatarajan V","year":"2019","unstructured":"Thiruvenkatarajan V, Meyer EJ, Nanjappa N, Van Wijk RM, Jesudason D. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review. Br J Anaesth. 2019, 123:27-36. 10.1016\/j.bja.2019.03.028","journal-title":"Br J Anaesth"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2019.12.006","article-title":"SGLT2 inhibitor-induced euglycemic diabetic ketoacidosis: a case report","volume":"2","author":"Wang KM","year":"2020","unstructured":"Wang KM, Isom RT. SGLT2 inhibitor-induced euglycemic diabetic ketoacidosis: a case report. Kidney Med. 2020, 2:218-21. 10.1016\/j.xkme.2019.12.006","journal-title":"Kidney Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13365","article-title":"Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type\u00a02 diabetes: a case report","volume":"12","author":"Kitahara C","year":"2021","unstructured":"Kitahara C, Morita S, Kishimoto S, et al.. Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type\u00a02 diabetes: a case report. J Diabetes Investig. 2021, 12:664-7. 10.1111\/jdi.13365","journal-title":"J Diabetes Investig"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000001380","article-title":"Intraoperative diagnosis of sodium-glucose cotransporter 2 inhibitor-associated euglycemic diabetic ketoacidosis: a case report","volume":"15","author":"Seger CD","year":"2021","unstructured":"Seger CD, Xing H, Wang L, Shin JS. Intraoperative diagnosis of sodium-glucose cotransporter 2 inhibitor-associated euglycemic diabetic ketoacidosis: a case report. A A Pract. 2021, 15:e01380. 10.1213\/XAA.0000000000001380","journal-title":"A A Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1039\/c8md00183a","article-title":"Sodium-glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class","volume":"9","author":"da Silva PN","year":"2018","unstructured":"da Silva PN, da Concei\u00e7\u00e3o RA, do Couto Maia R, de Castro Barbosa ML. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class. Medchemcomm. 2018, 9:1273-81. 10.1039\/c8md00183a","journal-title":"Medchemcomm"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1380","article-title":"Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors","volume":"38","author":"Rosenstock J","year":"2015","unstructured":"Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care. 2015, 38:1638-42. 10.2337\/dc15-1380","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13665","article-title":"Euglycemic diabetic ketoacidosis and sodium-glucose cotransporter-2 inhibitors: a focused review of pathophysiology, risk factors, and triggers","volume":"13","author":"Somagutta MR","year":"2021","unstructured":"Somagutta MR, Agadi K, Hange N, et al.. Euglycemic diabetic ketoacidosis and sodium-glucose cotransporter-2 inhibitors: a focused review of pathophysiology, risk factors, and triggers. Cureus. 2021, 13:e13665. 10.7759\/cureus.13665","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i5.514","article-title":"Euglycemic diabetic ketoacidosis: a missed diagnosis","volume":"12","author":"Nasa P","year":"2021","unstructured":"Nasa P, Chaudhary S, Shrivastava PK, Singh A. Euglycemic diabetic ketoacidosis: a missed diagnosis. World J Diabetes. 2021, 12:514-23. 10.4239\/wjd.v12.i5.514","journal-title":"World J Diabetes"},{"key":"ref18","unstructured":"SGLT2 inhibitor-induced euglycemic diabetic ketoacidosis. (2020). Accessed. October 18, 2024: https:\/\/www.renalfellow.org\/2020\/09\/08\/sglt2-inhibitor-induced-euglycemic-diabetic-ketoacidosis\/."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.06.006","article-title":"Inpatient perioperative euglycemic diabetic ketoacidosis due to sodium-glucose cotransporter-2 inhibitors - lessons from a case series and strategies to decrease incidence","volume":"28","author":"Mehta PB","year":"2022","unstructured":"Mehta PB, Robinson A, Burkhardt D, Rushakoff RJ. Inpatient perioperative euglycemic diabetic ketoacidosis due to sodium-glucose cotransporter-2 inhibitors - lessons from a case series and strategies to decrease incidence. Endocr Pract. 2022, 28:884-8. 10.1016\/j.eprac.2022.06.006","journal-title":"Endocr Pract"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1721","article-title":"SGLT2 inhibitor-associated euglycemic diabetic ketoacidosis: a South Australian clinical case series and Australian spontaneous adverse event notifications","volume":"41","author":"Meyer EJ","year":"2018","unstructured":"Meyer EJ, Gabb G, Jesudason D. SGLT2 inhibitor-associated euglycemic diabetic ketoacidosis: a South Australian clinical case series and Australian spontaneous adverse event notifications. Diabetes Care. 2018, 41:e47-9. 10.2337\/dc17-1721","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/262312-intraoperative-diagnosis-of-sodium-glucose-transporter-2-inhibitor-associated-euglycemic-diabetic-ketoacidosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T15:07:04Z","timestamp":1729436824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/262312-intraoperative-diagnosis-of-sodium-glucose-transporter-2-inhibitor-associated-euglycemic-diabetic-ketoacidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.71931","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,20]]}}}